(Q39738489)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20162269%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

title

Comparison of aggregation enhancement and inhibition as strategies for reducing the cytotoxicity of the aortic amyloid polypeptide medin (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20162269%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

0 references

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20162269%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

David A Middleton

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20162269%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

author name string

Jillian Madine

series ordinal

1

1 reference

14 September 2017

David A Middleton

series ordinal

2

1 reference

14 September 2017

publication date

17 February 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20162269%20AND%20SRC:MED&resulttype=core&format=json

European Biophysics Journal

18 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20162269%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

volume

39

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20162269%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20162269%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

page(s)

1281-1288

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20162269%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00249-010-0581-3

18 January 2020

exact match

0 references

cites work

New directions for neurodegenerative disease therapy: using chemical compounds to boost the formation of mutant protein inclusions

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00249-010-0581-3

The systemic amyloidoses: clearer understanding of the molecular mechanisms offers hope for more effective therapies

21 January 2018

1 reference

12 December 2020

Thioflavine T interaction with synthetic Alzheimer's disease beta-amyloid peptides: detection of amyloid aggregation in solution

1 reference

12 December 2020

Unwinding fibril formation of medin, the peptide of the most common form of human amyloid.

1 reference

12 December 2020

Negatively charged phospholipid membranes induce amyloid formation of medin via an alpha-helical intermediate

1 reference

12 December 2020

Evaluation of beta-alanine- and GABA-substituted peptides as inhibitors of disease-linked protein aggregation.

1 reference

12 December 2020

Role of aggregated medin in the pathogenesis of thoracic aortic aneurysm and dissection

1 reference

12 December 2020

Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis

1 reference

12 December 2020

Sulfate content and specific glycosaminoglycan backbone of perlecan are critical for perlecan's enhancement of islet amyloid polypeptide (amylin) fibril formation

1 reference

12 December 2020

Amyloid accomplices and enforcers

1 reference

12 December 2020

Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases

1 reference

12 December 2020

An important role of heparan sulfate proteoglycan (Perlecan) in a model system for the deposition and persistence of fibrillar A beta-amyloid in rat brain

1 reference

12 December 2020

Neurodegenerative disease: amyloid pores from pathogenic mutations.

1 reference

12 December 2020

Small molecule inhibitors of alpha-synuclein filament assembly

1 reference

12 December 2020

Molecular modeling of protein-glycosaminoglycan interactions.

1 reference

12 December 2020

Medin: an integral fragment of aortic smooth muscle cell-produced lactadherin forms the most common human amyloid

1 reference

12 December 2020

Heparin-binding properties of the amyloidogenic peptides Abeta and amylin. Dependence on aggregation state and inhibition by Congo red

1 reference

12 December 2020

Nature and significance of the interactions between amyloid fibrils and biological polyelectrolytes.

1 reference

12 December 2020

EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers

1 reference

12 December 2020

Heparin and other glycosaminoglycans stimulate the formation of amyloid fibrils from alpha-synuclein in vitro.

1 reference

12 December 2020

Protein misfolding, functional amyloid, and human disease

1 reference

12 December 2020

Pharmacological promotion of inclusion formation: a therapeutic approach for Huntington's and Parkinson's diseases

1 reference

12 December 2020

Cross-beta spine architecture of fibrils formed by the amyloidogenic segment NFGSVQFV of medin from solid-state NMR and X-ray fiber diffraction measurements.

1 reference

12 December 2020

Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death

1 reference

12 December 2020

Heparan sulphate proteoglycans in Alzheimer's disease and amyloid-related disorders

1 reference

12 December 2020

Synergistic action of polyanionic and non-polar cofactors in fibrillation of human islet amyloid polypeptide.

1 reference

12 December 2020

Conformational targeting of fibrillar polyglutamine proteins in live cells escalates aggregation and cytotoxicity

1 reference

12 December 2020

10.1007/S00249-010-0581-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20162269%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference